drugset / Trial / NCT01245140

Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis

NCT01245140

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main purpose of this study is to demonstrate the improvement in the skin condition rate of patients receiving alitretinoin compared to patients receiving placebo.

Timeline

Start
2011-04-26
Primary completion
2014-03-12
Completion
2014-04-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator alitretinoin Other / unclassified

Indications